Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial-Reference-Cited by-同舟云学术

Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial

Published:2012-02 Issue:1 Volume:5 Page:43-51
ISSN:1941-3149
Container-title:Circulation: Arrhythmia and Electrophysiology
language:en
Short-container-title:Circ Arrhythm Electrophysiol

Author:

Goette Andreas¹,Schön Norbert¹,Kirchhof Paulus¹,Breithardt Günter¹,Fetsch Thomas¹,Häusler Karl Georg¹,Klein Helmut U.¹,Steinbeck Gerhard¹,Wegscheider Karl¹,Meinertz Thomas¹

Affiliation:

1. From the University Hospital Magdeburg (A.G.), Magdeburg, Germany; Department of Cardiology and Intensive Care Medicine, St Vincenz-Hospital Paderborn (A.G.), Paderborn, Germany; Private Practice (N.S.), Mühldorf, Germany; Department of Cardiology and Angiology, University Hospital Münster (P.K.), Münster, Germany; University of Birmingham Centre for Cardiovascular Sciences (P.K.), Birmingham, UK; Institut für Klinisch-Kardiovaskuläre Forschung (T.F.), Munich, Germany; Klinik und Poliklinik für...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Epidemiologic Features of Chronic Atrial Fibrillation

2. Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study

3. Prevalence of Diagnosed Atrial Fibrillation in Adults

4. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management

5. Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial fibrillation burden: a new outcome predictor and therapeutic target;European Heart Journal;2024-07-02

2. Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications;Nature Reviews Cardiology;2024-05-30

3. Activated factor X stimulates atrial endothelial cells and tissues to promote remodelling responses through AT1R/NADPH oxidases/SGLT1/2;Cardiovascular Research;2024-05-14

4. Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference;Europace;2024-03-30

5. Incidence and progression of atrial fibrillation in patients with and without heart failure using mineralocorticoid receptor antagonists: a meta-analysis;Clinical Research in Cardiology;2024-01-03